Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Vertex Pharmaceuticals Cash Provided by (Used in) Operating Activity, Including Discontinued Operation increased by 186.8% to $1.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 74.4%, from $818.90M to $1.43B. Over 4 years (FY 2021 to FY 2025), Cash Provided by (Used in) Operating Activity, Including Discontinued Operation shows an upward trend with a 6.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Consistently positive and growing operating cash flow is a strong indicator of a healthy, self-sustaining business model.
Detailed definition
The total cash generated or consumed by the company's core business operations. It is the primary indicator of a company...
Peer comparison
The most important metric for assessing the fundamental cash-generating capability of any company.
other_net_cash_provided_by_used_in_operating_activitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $927.20M | $995.00M | $956.20M | $1.14B | $955.50M | $1.08B | $884.33M | $884.33M | $884.33M | $884.33M | -$123.15M | -$123.15M | -$123.15M | -$123.15M | $818.90M | $1.07B | $1.24B | $498.00M | $1.43B |
| QoQ Change | — | — | +7.3% | -3.9% | +19.2% | -16.2% | +12.9% | -18.0% | +0.0% | +0.0% | +0.0% | -113.9% | +0.0% | +0.0% | +0.0% | +765.0% | +31.0% | +15.7% | -59.9% | +186.8% |
| YoY Change | — | — | — | — | — | +3.1% | +8.4% | -7.5% | -22.4% | -7.4% | -18.0% | -113.9% | -113.9% | -113.9% | -113.9% | +765.0% | +971.4% | >999% | +504.4% | +74.4% |
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation?
- Vertex Pharmaceuticals (VRTX) reported cash provided by (used in) operating activity, including discontinued operation of $1.43B in Q1 2026.
- How has Vertex Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Vertex Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation increased by 74.4% year-over-year, from $818.90M to $1.43B.
- What is the long-term trend for Vertex Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's cash provided by (used in) operating activity, including discontinued operation has grown at a 6.3% compound annual growth rate (CAGR), from $2.84B to $3.63B.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- The net cash flow resulting from the company's day-to-day business activities.